IL76683A0 - Pharmaceutical compositions for treating symptoms caused by htlv viruses - Google Patents

Pharmaceutical compositions for treating symptoms caused by htlv viruses

Info

Publication number
IL76683A0
IL76683A0 IL76683A IL7668385A IL76683A0 IL 76683 A0 IL76683 A0 IL 76683A0 IL 76683 A IL76683 A IL 76683A IL 7668385 A IL7668385 A IL 7668385A IL 76683 A0 IL76683 A0 IL 76683A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
symptoms caused
treating symptoms
htlv viruses
htlv
Prior art date
Application number
IL76683A
Other languages
English (en)
Original Assignee
Us Commerce
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Commerce filed Critical Us Commerce
Publication of IL76683A0 publication Critical patent/IL76683A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL76683A 1984-10-12 1985-10-13 Pharmaceutical compositions for treating symptoms caused by htlv viruses IL76683A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US66013784A 1984-10-12 1984-10-12

Publications (1)

Publication Number Publication Date
IL76683A0 true IL76683A0 (en) 1986-02-28

Family

ID=24648309

Family Applications (1)

Application Number Title Priority Date Filing Date
IL76683A IL76683A0 (en) 1984-10-12 1985-10-13 Pharmaceutical compositions for treating symptoms caused by htlv viruses

Country Status (4)

Country Link
EP (1) EP0183352A2 (xx)
AU (1) AU5012285A (xx)
IL (1) IL76683A0 (xx)
WO (1) WO1986002266A1 (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9024738D0 (en) * 1990-11-14 1991-01-02 Erba Carlo Spa A new method of treatment of tumor necroisis factor(tnf)-related diseases
GB9216962D0 (en) * 1992-08-11 1992-09-23 Erba Carlo Spa Therapeutically active naphthalenesulfonic-pyrrolecarboxamido derivatives
GB9304589D0 (en) * 1993-03-05 1993-04-21 Erba Carlo Spa Biologically active ureido derivatives useful as antimetastic agents
AU2002213132A1 (en) * 2000-10-10 2002-04-22 Board Of Regents, The University Of Texas System Suppression of cyclin kinase activity for prevention and treatment of infections
JP2004530700A (ja) * 2001-05-18 2004-10-07 エンダシア，インコーポレイテッド Ａ１アデノシン及びｐ２ｘプリン受容体拮抗薬を使用する方法及び製剤
WO2003082193A2 (en) 2002-03-26 2003-10-09 Eastern Virginia Medical School Suramin and derivatives thereof as topical microbicide and contraceptive
WO2012019991A1 (en) * 2010-08-09 2012-02-16 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of hiv-1 infections
DK2670404T3 (en) * 2011-02-02 2018-11-19 Univ Princeton CIRCUIT MODULATORS AS VIRUS PRODUCTION MODULATORS
JP7749169B2 (ja) * 2019-06-07 2025-10-06 クヴァトリス セラピューティクス， インコーポレイテッド 中枢神経系障害を処置するための組成物および方法

Also Published As

Publication number Publication date
WO1986002266A1 (en) 1986-04-24
AU5012285A (en) 1986-05-02
EP0183352A2 (en) 1986-06-04

Similar Documents

Publication Publication Date Title
DE3361644D1 (en) Photopolymerizable compositions
GB8326565D0 (en) Pharmaceutical compositions
GB8327612D0 (en) Pharmaceutical compositions
GB8403359D0 (en) Pharmaceutical compositions
GB8426672D0 (en) Pharmaceutical compositions
GB2165451B (en) Pharmaceutical compositions
GB8410290D0 (en) Pharmaceutical compositions
ZA79335B (en) Pharmaceutical composition for deactivating viruses
ZA833781B (en) Pharmaceutical compositions
GB2159055B (en) Pharmaceutical compositions of 3,7,11,15-tetra-methylhexadec-1-en-3-ol
GB8410289D0 (en) Pharmaceutical compositions
GB2118176B (en) Pharmaceutical compositions
IL76683A0 (en) Pharmaceutical compositions for treating symptoms caused by htlv viruses
PT77323B (en) Pharmaceutical compositions
GB2117766B (en) Pharmaceutical compositions
GB8429749D0 (en) Pharmaceutical compositions
GB8409961D0 (en) Pharmaceutical compositions
FR2523408B1 (fr) Compositions edulcorantes de table
DE3377696D1 (en) Pharmaceutical compositions
GB2114001B (en) Nasel pharmaceutical compositions
GB8330810D0 (en) Pharmaceutical compositions
GB8314736D0 (en) Pharmaceutical compositions
MA20554A1 (fr) Procede de preparation de compositions de
EP0178076A3 (en) Organo-silicone compounds, process for their manufacture, and pharmaceutical compositions thereof
GB8331068D0 (en) Pharmaceutical compositions